<DOC>
	<DOCNO>NCT02265484</DOCNO>
	<brief_summary>After successful screen liver cirrhosis patient attend ILBS OPD sign parkinsonism ( tremor , rigidity bradykinesia , 2 3 ) . Diagnosis hepatic/cirrhosis relate parkinsonism make . Patients randomized Bromocriptine Placebo . Patients follow every month OPD ( Out Patient Department ) , ILBS ( Institute liver &amp; Biliary Sciences ) 3 month . Detailed neurological examination do visit &amp; UPDRS ( Unified Parkinson 's Disease Rating Scale ) score calculate .</brief_summary>
	<brief_title>To Study Efficacy Bromocriptine Patients With Hepatic/Cirrhosis Related Parkinsonism</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Parkinsonian Disorders</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Lactulose</mesh_term>
	<mesh_term>Bromocriptine</mesh_term>
	<criteria>Patients cirrhosis liver sign parkinsonism Patients consent study protocol signing informed consent . Age &lt; 18 year . Patient HCC ( Hepatocellular Carcinoma ) . Patients diagnosed Wilsons disease . Patient withdraw non complaint study protocol . ALF ( Acute Liver failure ) Classical Parkinsonism Atypical Parkinsonism Pregnancy Hypotension Uncontrolled hypertension CAD Psychiatric illness Acute episode Hepatic encephlopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>